Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • NCD 2025
NET Nurse
Donate

Home » Advocacy » NECA Team’s Advocacy Efforts Extend to 13 Industry Boards and working groups for Neuroendocrine Cancer Patients

NECA Team’s Advocacy Efforts Extend to 13 Industry Boards and working groups for Neuroendocrine Cancer Patients

  • February 23, 2024

Recognising the critical importance of collaboration and advocacy behind the scenes, the NECA Team embraces the opportunity to contribute to shaping the landscape for Neuroendocrine Cancer patients.

By sitting on this group of diverse boards, working and study groups, the team ensures a comprehensive and informed approach to addressing the unique challenges faced by individuals diagnosed with neuroendocrine cancer.

  • Cancer Nurses Association of Australia (CNSA) – Vice President, Board of Directors
  • Coalition of National Nursing Organisations (CoNNMO) – Council
  • Alliance & Partnerships for Patient Innovation & Solutions (APPIS) – Council, Expert Advisory Panel
  • International Neuroendocrine Cancer Alliance (INCA) – Board of Directors, Chair of Research Committee
  • Australian Cancer Nurse Navigation Program – Expert Advisory Group, Telehealth Nurse Working Group
  • NSW Health Consumers  – Consumer Organisations Taskforce
  • Cancer Organisations Collaboration – representative Non Government organisations
  • The Australasian Association of Nuclear Medicine Specialists (AANMS) Theranostics Meeting
  • Commonwealth Neuroendocrine Tumour research collaborative (CommNETs) Working Group
  • AUSNET Study Group
  • North Foundation Development Committee
  • NET Nurse Special Interest Group

Through these collaborative efforts, the NECA Team aims to amplify the voices of patients and advocate for improved resources, research, and support networks.

The NECA Team extends gratitude to the boards and their members for the opportunity to contribute to the collective mission of enhancing the lives of Neuroendocrine Cancer patients.

As the advocacy journey continues, the NECA Team remains steadfast in its commitment to making a meaningful impact and fostering positive change within the Neuroendocrine Cancer community.

Share this post

Recent posts

Rare Cancers Roundtable

September 26, 2025

Shining a Light for World Neuroendocrine Cancer Day – Help Us Light Up Australia

September 26, 2025

Celebrating Shane Kent’s Arch2Arc Journey and Fundraising

September 20, 2025

Will Norman Nurse Webinar on Neuroendocrine Cancer

September 19, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousTamworth local Ryan Harding advocates for VHL patients to have access to Belzutifan
NextThe David Trophy 2024Next

Related Posts

Rare Cancers Roundtable

NECA recently attended a Rare Cancers Roundtable to discuss “The value of cancer clinical trials and setting up for success.” Attendees were diverse, including industry,

Shining a Light for World Neuroendocrine Cancer Day – Help Us Light Up Australia

Each year on 10 November for World Neuroendocrine Cancer Day, NeuroEndocrine Cancer Australia joins the global movement to raise awareness of Neuroendocrine Tumours (NETs). This

Will Norman Nurse Webinar on Neuroendocrine Cancer

On 17 September, NeuroEndocrine Cancer Australia, NeuroEndocrine UK, and NeuroEndocrine New Zealand came together to deliver the Will Norman Nurse Webinar on Neuroendocrine Cancer. Hosted

13th INCA Global NET Patient Advocate Summit

This week our CEO Meredith Cummins, in her role as President Elect of the INCA Board of Directors and Chair of the Research Committee, presented at

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin